enVVeno Medical Corp (NVNO)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $4.29M
Last updated: Nov 17, 2026 at 4:43 PM ET
enVVeno Medical Corp (NVNO) Statistics
enVVeno Medical (NVNO) has a market cap of $4.29M and an enterprise value of $1.70M. Revenue fell 100.00% over the last 12 months from the 12 months before. It holds $2.58M more cash than debt, 60.30% of its market cap.
Total Valuation
Enterprise value is 60.30% below the market cap, as cash exceeds debt.
| Market Cap | $4.29M |
|---|---|
| Enterprise Value | $1.70M |
| Latest price (Nov 17, 2026) | $5.77 |
Key Dates
The next earnings report is expected on Mar 24, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 24, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 29, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 60.75% over 52 weeks and trades 26.78% below its 50-day average.
| Beta (1Y) | 0.89 |
|---|---|
| 52-Week Change | -60.75% |
| 1-Month Change | -24.97% |
| 3-Month Change | -44.94% |
| 6-Month Change | -43.15% |
| 5-Year Change | -97.82% |
| Total Return (1Y) | -60.75% |
| Total Return (3Y CAGR) | -65.98% |
| Total Return (5Y CAGR) | -52.97% |
| Return vs SPY (1Y) | -61.56% |
| Max Drawdown (1Y) | -58.54% |
| Max Drawdown (3Y) | -97.52% |
| Sharpe Ratio (1Y) | -0.88 |
| Correlation with SPY (1Y) | 0.16 |
| 50-Day Average | $7.88 |
| 200-Day Average | $10.03 |
| 52-Week Range | $5.80 to $14.66 |
| RSI (14 Days) | 28.7 |
| Average Volume (20 Days) | 28.96K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 7.35x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 7.35x |
|---|---|
| Quick Ratio | 7.35x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -92.02% over the last 12 months, against a 5-year average of -53.70%.
| Return on Equity (ROE) | -92.02% |
|---|---|
| Return on Assets (ROA) | -79.80% |
| ROE (5Y Average) | -53.70% |
| ROA (5Y Average) | -50.12% |
| ROIC (5Y Average) | -58.72% |
Scores
NVNO has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 1 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Revenue Growth (YoY) | -100.00% |
| Gross Profit | -$117.00K |
| Operating Income | -$16.41M |
| Pretax Income | -$15.55M |
| Net Income | -$15.55M |
| EBITDA | -$15.32M |
| Reported EPS (TTM) | -$23.46 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 86.71% of the $19.49M in total assets.
| Cash and Equivalents | $2.58M |
|---|---|
| Total Debt | $0 |
| Net Cash | $2.58M |
| Net Cash Per Share | $3.72 |
| Working Capital | $16.43M |
| Shareholder Equity | $16.90M |
| Book Value Per Share | $24.35 |
| Total Assets | $19.49M |
| Total Liabilities | $2.59M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$13.41M |
|---|---|
| FCF Per Share | -$19.30 |
| Depreciation and Amortization | $506.00K |
Trailing 12 months through Sep 30, 2026.
Dividends and Yields
NVNO does not pay a dividend.
| Buyback Yield | -24.20% |
|---|---|
| Shareholder Yield | -24.20% |
Stock Splits
The last split was a 1-for-35 reverse split on Jan 20, 2026.
| Last Split Date | Jan 20, 2026 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:35 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About NVNO
What is NVNO's market cap?
enVVeno Medical has a market cap of $4.29M. Its enterprise value, which adds debt and subtracts cash, is $1.70M.
How many shares of NVNO are outstanding?
enVVeno Medical has 694.00K shares outstanding.
Does NVNO pay a dividend?
No. enVVeno Medical does not pay a dividend.
How much debt does NVNO have?
enVVeno Medical has $0 of total debt and $2.58M of cash and equivalents, a net cash position of $2.58M.
NVNO pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors